Consistency of response across subgroups of patients with psoriasis treated with guselkumab: Results from the VOYAGE 1 and 2 trials

被引：0
|
作者：
Blauvelt, Andrew [1 ]
Reich, Kristian [2 ]
Papp, Kim A. [3 ]
Griffiths, Christopher E. M. [4 ]
Armstrong, April W. [5 ]
Foley, Peter [6 ,7 ]
Shen, Yaung-Kaung [8 ]
Kimball, Alexa B. [9 ]
Gordon, Kenneth B. [10 ]
机构：
[1] Oregon Med Res Ctr, Portland, OR USA
[2] Dermatologikum Hamburg, Hamburg, Germany
[3] K Papp Clin Res & Prob Res Inc, Waterloo, ON, Canada
[4] Univ Manchester, Manchester Acad Hlth Sci Ctr, Salford Royal Hosp, Dermatol Ctr, Manchester, Lancs, England
[5] Univ Southern Calif, Los Angeles, CA USA
[6] Univ Melbourne, St Vincents Hosp, Melbourne, Vic, Australia
[7] Skin & Canc Fdn Inc, Carlton, Vic, Australia
[8] Janssen Res & Dev LLC, Raritan, NJ USA
[9] Harvard Med Sch, Dept Dermatol, Boston, MA USA
[10] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2017年 / 76卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
4895
引用
收藏
页码：AB83 / AB83
页数：1
相关论文
共 50 条
  • [1] Consistency of response by weight across subgroups of patients with psoriasis treated with guselkumab: Results from the VOYAGE 1 and 2 trials
    Papp, Kim
    Crowley, Jeffrey
    Rubel, Diana
    Landells, Ian
    Song, Michael
    Wasfi, Yasmine
    You, Yin
    Shen, Yaung-Kaung
    Thaci, Diamant
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB87 - AB87
  • [2] CONSISTENCY OF RESPONSE BY WEIGHT ACROSS SUBGROUPS OF PATIENTS WITH PSORIASIS TREATED WITH GUSELKUMAB: RESULTS FROM THE VOYAGE 1 AND 2 TRIALS
    Papp, Kim
    Crowley, Jeffrey
    Rubel, Diana
    Landells, Ian
    Song, Michael
    Wasfi, Yasmine
    You, Yin
    Shen, Yaung-Kaung
    Thaci, Diamant
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 20 - 20
  • [3] Consistency of response maintained across demographic subgroups of psoriasis patients treated with guselkumab for up to 3 years in the VOYAGE 1 and 2 trials
    Blauvelt, A.
    Reich, K.
    Spelman, L.
    Bagel, J.
    Bissonnette, R.
    Gerdes, S.
    Fakharzadeh, S.
    Song, M.
    Shen, Y. -K.
    Gordon, K. B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 52 - 53
  • [4] Consistency of response maintained across demographic subgroups of psoriasis patients treated with guselkumab for up to 3 years in the VOYAGE 1 and 2 trials
    Blauvelt, A.
    Reich, K.
    Spelman, L.
    Bagel, J.
    Bissonnette, R.
    Gerdes, S.
    Fakharzadeh, S.
    Song, M.
    Shen, Y-K
    Gordon, K. B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB38 - AB38
  • [5] Consistency of response (PASI 90 or 100 and IGA 0 or 0/1) in patients with moderate to severe psoriasis treated with guselkumab: Results from the VOYAGE 1 and 2 trials
    Gordon, Kenneth
    Menter, Alan
    Ferris, Laura
    Martorell, Antonio
    Kim, Byung Soo
    Song, Michael
    Wasfi, Yasmine
    You, Yin
    Shen, Yaung-Kaung
    Langley, Richard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB87 - AB87
  • [6] Efficacy responses across subgroups of patients with moderate to severe plaque psoriasis treated with Guselkumab: Results from VOYAGE 1 through 5 years
    Thaci, D.
    Foley, P.
    Puig, L.
    Merola, J. F.
    Miller, M.
    You, Y.
    Shen, Y. -K.
    Yang, Y. -W.
    Blauvelt, A.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 41 - 42
  • [7] Consistency of infliximab response across subgroups of patients with psoriasis: Integrated results from randomized clinical trials
    Reich, K
    Gottlieb, AB
    Kimball, A
    Li, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB215 - AB215
  • [8] Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials
    Blauvelt, Andrew
    Thaci, Diamant
    Papp, Kim A.
    Ho, Vincent
    Ghoreschi, Kamran
    Kim, Byung Soo
    Miller, Megan
    Shen, Yaung-Kaung
    You, Yin
    Chan, Daphne
    Yu, Jenny
    Yang, Ya-Wen
    Lebwohl, Mark G.
    Gottlieb, Alice B.
    Crowley, Jeffrey
    Foley, Peter
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (01) : 132 - 134
  • [9] EFFICACY RESPONSES ACROSS DISEASE SEVERITY AND TREATMENT HISTORY SUBGROUPS OF PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS TREATED WITH GUSELKUMAB: POOLED RESULTS FROM VOYAGE-1 AND VOYAGE-2 THROUGH 5 YEARS
    Gordon, K.
    Merola, J. F.
    Foley, P.
    Choi, O.
    Chan, D.
    Miller, M.
    You, Y.
    Shen, Y. K.
    Yang, Y. W.
    Blauvelt, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1842 - 1842
  • [10] Immunogenicity of Guselkumab among psoriasis patients in VOYAGE 1 and VOYAGE 2
    Reich, K.
    Armstrong, A. W.
    Zhu, Y.
    Miller, M.
    You, Y.
    Shen, Y. -K.
    Yang, Y. W.
    Foley, P.
    Griffiths, C. E. M.
    Strober, B.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 42 - 42
12345